Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK ( TheStreet) -- If you care about making money, stocks are still the only place to be, Jim Cramer told his "Mad Money" TV show viewers Monday, after another up day on Wall Street. Cramer said the bears are beginning to come out in droves, proclaiming that the top has arrived, but that simply isn't the case. With the markets up 24% for the year, Cramer said, history remains on investors' side. Historically, markets that are up more than 20% going into November have only added to their gains. Stocks have been a great place to be since the lows of March 2009. Add to that a steaming hot IPO market, and the effectively nonexistent yield from all other forms of investments and it's easy to see why stocks remain the place to be. There are no real alternatives to stocks, Cramer continued, and with the S&P 500 trading at just 14.7 times forward earnings, stocks really aren't that expensive either. Some sectors, like biotech, continue to rally with names like Celgene ( CELG), Gilead Sciences ( GILD - Get Report) and Regeneron ( REGN - Get Report) continuing to shine. Yes, there are some stocks, like the newly minted Twitter ( TWTR - Get Report), that ARE wildly expensive, but that doesn't apply to the market at large. The analysts who are calling for a top in the market are those who never had any conviction in the rally to begin with, Cramer said, but in reality, stocks remain the only game in town.
Executive Decision: Dave MelcherIn the "Executive Decision" segment, Cramer spoke with Dave Melcher, president and CEO of Exelis ( XLS), the defense contractor that's seen its shares rise 66% since Cramer last checked in back in September 2012. Despite the ongoing sequester, shares of Exelis still offer a 2.6% yield. Melcher started off commenting on Veterans Day, noting that veterans are the fabric of America and offer many talents to the companies who hire them. Nearly 10% of Exelis' workforce are veterans, he said, adding that hiring vets is just "the right thing to do." Turning to the business of Exelis, Melcher said that while his company can't control the top line given the continued budgets cuts, it does have control of the bottom line, which is why it has been cutting costs and reducing head counts where to bolster earnings.
Priceline.com in SpotlightDon't freak out over its price tag, shares of Priceline.com ( PCLN) are worth every penny, Cramer told viewers, as he highlighted the travel Web site that's given investors a 1,909% return over the past five years, 77% of which came from this year alone. Cramer called Priceline THE growth stock to own going into the end of the year, as it currently trades for just 19 times earnings despite a 20% growth rate. He reminded viewers that money managers will pay up to twice a company's growth rate, or 40 times earnings, for a stock like Priceline, which is why the stock is incredibly cheap at its current valuation. While its true that Priceline has been rallying for years, Cramer said the company remains the best of breed playing in a secular growth industry. The company has a big exposure to Europe, which is finally taking a turn for the better, and it also derives 75% of its revenues from lucrative hotel bookings and far less from cut-throat airline reservations. Priceline also uses an agency model, acting as a broker between buyers and sellers, taking a 15% to 20% cut of the transaction fee. That makes it a far safer bet than its peers, Cramer said, especially given its scale. Priceline also snapped up Kayak, making it a big player in the fast-growing mobile bookings space. Given the company's huge cash flows, which afford it lots of options for buybacks, dividends and future acquisitions, Cramer said that Priceline should be on everyone's wish list this year. While some fretted over the companies' recent guidance, Cramer reminded viewers that Priceline is renowned for its tepid guidance, which explains the stock's $100 swing from its post-earnings selloff to its close the following day.